文献速递疼痛医学

STEPP简短创伤聚焦干预用于慢性疼痛的可行性初步研究

Pilot study of feasibility, acceptability, and changes in clinical outcomes following a brief trauma-focused intervention for chronic pain.
PubMed 文献 · Reg Anesth Pain Med · 2026-06-25

单臂初步研究纳入42例伴创伤暴露的混合病因慢性疼痛成人,远程实施3次每周1小时个体化STEPP干预。招募、治疗及随访完成率均达预设可行性基准,THQ评分高;疼痛强度、疼痛干扰、PTSD症状、疼痛灾难化及运动恐惧从基线至治疗后显著改善并维持至3个月。

要点

  • STEPP远程3次个体化 sessions 可行且可接受,完成率达标。
  • 疼痛强度变化小,其余结局改善中度至较大。
  • 需随机对照试验确认疗效。

核心结论

  • STEPP在伴创伤暴露的慢性疼痛成人中显示可行性与可接受性,疼痛相关及创伤相关结局有改善趋势。

研究设计与样本

  • 单臂初步研究,纳入42例混合病因慢性疼痛且伴创伤暴露的成人,远程实施3次每周1小时个体化STEPP干预。

主要发现

  • 可行性基准均达标:93%合格者入组,90%入组者开始治疗,97%开始者完成治疗。
  • 完成者随访完成率:治疗后100%,1个月和3个月均为97%。
  • THQ评分高且达标:治疗后M=4.0±1.2,1个月M=3.9±1.2,3个月M=3.8±1.3。
  • 可信度评分达标,期望评分未达标。
  • 基线至治疗后显著改善:疼痛强度平均变化-0.64(SE=0.23,95%CI -1.11至-0.18),疼痛干扰-3.34(SE=0.84,95%CI -5.00至-1.68),PTSD症状-5.60(SE=1.53,95%CI -8.64至-2.57),疼痛灾难化-6.69(SE=1.34,95%CI -9.34至-4.03),运动恐惧-5.78(SE=1.21,95%CI -8.19至-3.37),维持至3个月。

关键数值与推荐

  • 可行性基准预设为≥70%,覆盖招募、治疗及随访完成率。
  • 可接受性采用THQ(-5至5)和可信度与期望问卷(内容可信度及预期获益;3-27)评估。
  • 疼痛强度量表0-10,功能干扰0-100,PTSD症状0-80,疼痛灾难化0-52,运动恐惧17-68。

临床怎么用

  • STEPP可作为伴创伤暴露慢性疼痛患者的简短远程干预选项,但需随机对照试验确认疗效后再推广。

局限性

  • 单臂设计无对照组,无法确定疗效。
  • 样本量小(N=42),结果需更大样本验证。
  • 期望评分未达可接受性基准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trauma exposure is prevalent among individuals with chronic pain and is associated with poorer pain-related outcomes. Brief, scalable interventions that target overlapping trauma-pain processes are needed. This single-arm pilot study evaluated feasibility, acceptability, and changes in clinical outcomes following Stress, Trauma, and Emotional Processing for Pain (STEPP), a brief modified version of emotional awareness and expression therapy. METHODS: Adults (N=42) with mixed-etiology chronic pain and trauma exposure were enrolled. STEPP was delivered remotely over three weekly 1-hour individual sessions. Participants completed questionnaires at baseline, post-treatment, and 1-month, and 3-month follow-up. Feasibility benchmarks (≥70%) were prespecified for recruitment, treatment, and follow-up completion. Acceptability was assessed using the Treatment Helpfulness Questionnaire (THQ; -5 to 5) and Credibility and Expectancy Questionnaire (content credibility and expected benefit; 3-27). Linear mixed models and Hedges' g effect sizes examined changes in pain intensity (0-10) and interference with functioning (0-100), post-traumatic stress disorder symptoms (PTSD; 0-80), pain catastrophizing (concerns about pain; 0-52), and kinesiophobia (fear of movement; 17-68). RESULTS: All feasibility benchmarks were met. 93% of eligible participants enrolled, 90% of enrolled participants initiated treatment, and 97% initiators completed treatment. Among completers, follow-up completion was 100% at post-treatment and 97% at 1 and 3 months. THQ ratings were high and met benchmarks (post M=4.0±1.2; 1-month M=3.9±1.2; 3-month M=3.8±1.3). Credibility ratings met benchmarks, whereas expectancy ratings did not. Significant improvements were observed from baseline to post-treatment: pain intensity (mean change=-0.64, SE=0.23, 95% CI -1.11 to -0.18), pain interference (-3.34, SE=0.84, 95% CI -5.00 to -1.68), PTSD (-5.60, SE=1.53, 95% CI -8.64 to -2.57), pain catastrophizing (-6.69, SE=1.34, 95% CI -9.34 to -4.03), and kinesiophobia (-5.78, SE=1.21, 95% CI -8.19 to -3.37); changes were maintained through 3 months. Effect sizes were small for pain intensity and moderate-to-large for all other outcomes. CONCLUSIONS: STEPP demonstrated feasibility and acceptability, with promising improvements in pain-related and trauma-related outcomes. Randomized controlled trials are needed to establish efficacy.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Yamin JB, Wilson JM, Sturgeon JA, et al. Pilot study of feasibility, acceptability, and changes in clinical outcomes following a brief trauma-focused intervention for chronic pain. Reg Anesth Pain Med. 2026. PMID: 42350064. doi:10.1136/rapm-2026-107849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。